Review Molecular medicine reports 2025

Hyperbaric oxygen therapy for sudden sensorineural hearing loss (Review).

Sun Y, Wang S, Fu H, Ge X, Pan S — Molecular medicine reports, 2025

View Original on PubMed PMID 40910260

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

This review explored the biological mechanisms, clinical efficacy, and existing controversies of hyperbaric oxygen therapy (HBOT) for sudden sensorineural hearing loss (SSNHL).

What They Found

Researchers found that hyperbaric oxygen therapy (HBOT) combined with glucocorticoids can significantly improve treatment outcomes for sudden sensorineural hearing loss (SSNHL), especially with early intervention. However, the optimal clinical application of HBOT remains undetermined due to a lack of standardised treatment parameters and inconsistent results from clinical studies.

Canadian Relevance

This review does not have a direct Canadian connection.

Study Limitations

A key limitation is the lack of standardised treatment parameters for hyperbaric oxygen therapy and inconsistent results across existing clinical studies.

This plain-language summary is generated with AI assistance and checked against the source abstract before publication. See our editorial policy.

Was this summary helpful?

Study Details

Study Type	Review
Category	Sudden Hearing Loss
Source	Pubmed
PubMed ID	40910260
Year Published	2025
Journal	Molecular medicine reports
MeSH Terms	Humans; Hyperbaric Oxygenation; Hearing Loss, Sensorineural; Hearing Loss, Sudden; Treatment Outcome; Oxygen; Animals

Related Research

JAMA Otolaryngol | 2022 Meta-Analysis ★

Hyperbaric oxygen therapy for patients with sudden sensorineural hearing loss: a systematic review and meta-analysis

Joshua TG, Ayub A, Bhatt J, et al.

Otolaryngol Head Neck Surg | 2019 Clinical Guideline

Clinical practice guideline: sudden hearing loss (update)

Chandrasekhar SS, Tsai Do BS, Schwartz SR, et al.

Eur Arch Otorhinolaryngol | 2015 Prospective Study

Hyperbaric oxygen therapy as salvage treatment for sudden sensorineural hearing loss: a prospective controlled study

Pezzoli M, Magnano M, Maffi L, et al.

Audiol Neurootol | 2022 Prospective Study

Efficacy of Hyperbaric Oxygen on Idiopathic Sudden Sensorineural Hearing Loss and Its Correlation with Treatment Course: Prospective Clinical Research.

Huang C, Liu W, Zhang Z, et al.

Cochrane | 2012 Cochrane Review

Hyperbaric oxygen for idiopathic sudden sensorineural hearing loss and tinnitus

Bennett MH, Kertesz T, Perleth M, et al.

This study relates to Sudden Sensorineural Hearing Loss. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

See all Sudden Hearing Loss research

View on PubMed Back to Research Library

Find a Canadian Clinic Treating Sudden Hearing Loss

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last reviewed: April 2, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology